Trendpublic

📅SEC Meeting Schedule Change Notification - January 2025

⚠️Columbia Gas Transmission Notice on Well Abandonment Compliance

⚖️Combined Notice of Filings from the Federal Energy Regulatory Commission

📦USPS Priority Mail and Ground Advantage Service Agreement Notice

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

🍽️Important Public Meeting on Food Additives Regulations in 2025

The U.S. Codex Office is sponsoring a public meeting on February 18, 2025, from 9 a.m. to 12 p.m. eastern time (ET). The objective of the public meeting is to provide information and receive public comments on agenda items and draft U.S. positions to be discussed at the 55th Session of the Codex Committee on Food Additives (CCFA) of the Codex Alimentarius Commission, which is scheduled to be held in Seoul, Republic of Korea, from March 24-28, 2025. The U.S. Manager for Codex Alimentarius and the Under Secretary for Trade and Foreign Agricultural Affairs recognize the importance of providing interested parties the opportunity to obtain background information on the 55th Session of the CCFA and to address items on the agenda.

📜Change in Bank Control Notices

📦USPS Priority Mail Contract Change Notice for Businesses

The Postal Service gives notice of filing a request with the Postal Regulatory Commission to add a domestic shipping services contract to the list of Negotiated Service Agreements in the Mail Classification Schedule's Competitive Products List.

🗓️Amended Notice of National Cancer Institute Meeting Reschedule

⚖️Notice of Inventory Completion Under NAGPRA for Northwestern University

In accordance with the Native American Graves Protection and Repatriation Act (NAGPRA), Northwestern University has completed an inventory of human remains and associated funerary objects and has determined that there is a cultural affiliation between the human remains and associated funerary objects and Indian Tribes or Native Hawaiian organizations in this notice.

💊FDA Issues Priority Review Voucher for Rare Pediatric Disease Product

The Food and Drug Administration (FDA) is announcing the issuance of a priority review voucher to the sponsor of a rare pediatric disease product application. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to award priority review vouchers to sponsors of approved rare pediatric disease product applications that meet certain criteria. FDA is required to publish notice of the award of the priority review voucher. FDA has determined that ALHEMO (concizumab-mtci), approved on December 20, 2024, manufactured by Novo Nordisk, Inc., meets the criteria for a priority review voucher.